Who is sponsoring NCT04073420?

NCT04073420 is sponsored by Medtronic Cardiac Surgery.

What drugs are being tested in NCT04073420?

Interventions in NCT04073420: Surgical Heart Valve Repair Products, Surgical Heart Valve Replacement Products.

What condition does NCT04073420 study?

NCT04073420 studies Valve Disease, Heart.

Is NCT04073420 still recruiting?

NCT04073420 is currently recruiting now. Last updated 13 April 2026.

Last reviewed 2026-04-13 · How we verify

NCT04073420

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Medtronic Cardiac Surgery PMCF Registry

Recruiting now Last updated 13 April 2026

What this trial tests

trial testing Surgical Heart Valve Repair Products in Valve Disease, Heart in 2,700 participants. Currently enrolling.

Timeline

2 December 2019

Primary endpoint
31 December 2039

31 December 2039

Quick facts

Lead sponsor	Medtronic Cardiac Surgery
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	2,700
Start date	2 December 2019
Primary completion	31 December 2039
Estimated completion	31 December 2039
Sites	26 locations across France, Italy, Netherlands, Greece, Belgium, Austria, Germany, Switzerland

Drugs / interventions tested

Surgical Heart Valve Repair Products
Surgical Heart Valve Replacement Products

Conditions studied

Valve Disease, Heart — all drugs for Valve Disease, Heart →

Sponsor

Medtronic Cardiac Surgery — full company profile →

Who can join

Eligibility, any sex, with Valve Disease, Heart. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This registry is being conducted to support ongoing post-market surveillance activities.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Valve Disease, Heart

Currently open trials in the same condition.

NCT06917586 — Mosaic Mitral Valve: Long-Term Outcomes in Patients Under 65 · recruiting
NCT06387446 — Allogeneic Valve Transplantation · NA · recruiting
NCT05139589 — The ENDOCARDITIS AUMC Data Collection · recruiting
NCT05972070 — Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence · recruiting

Other Medtronic Cardiac Surgery trials

Trials by the same sponsor.

NCT04241328 — Medtronic SYMBIOSIS Post-Market Registry for Patients Undergoing Cardiac Surgery · recruiting
NCT03139721 — Medtronic HAMMOCK Post Approval Study · completed
NCT03283722 — PRESERVE-MITRAL Post-Market Registry · completed
NCT02088554 — PERIGON Pivotal Trial · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04073420 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medtronic Cardiac Surgery
Last refreshed: 13 April 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04073420.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing